| Tierra Janay Simmons, MD | |
|
1095 Midway Rd, Menasha, WI 54952-1115 | |
| (920) 720-2300 | |
| (920) 720-3719 |
| Full Name | Tierra Janay Simmons |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1095 Midway Rd, Menasha, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306306006 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 89785 (Georgia) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 82451 (Wisconsin) | Primary |
| Entity Name | Thedacare Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376656959 PECOS PAC ID: 1759294887 Enrollment ID: O20031106000088 |
News Archive
maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.
Merck, known as MSD outside the United States and Canada, today announced the first presentation of results from an interim analysis of KEYNOTE-057, a Phase 2 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for previously treated patients with high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ or CIS plus papillary disease (Cohort A).
The grants, which are to be used to set up the framework for the health law's state insurance exchanges, will reportedly go to Kansas, Maryland, New York, Oklahoma, Oregon, Wisconsin and a consortium led by Massachusetts.
Results from a pre-clinical study show that the gene designated Bcl-6 is an oncogene - that is, one with the potential to cause a normal cell to become cancerous - but that certain peptide inhibitors can in effect inactivate it, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tierra Janay Simmons, MD 1441 Woodmount Ln Nw, #937, Atlanta, GA 30318 Ph: (404) 907-0480 | Tierra Janay Simmons, MD 1095 Midway Rd, Menasha, WI 54952-1115 Ph: (920) 720-2300 |
News Archive
maxIT Healthcare, LLC and Ingenuity Solutions Group, Inc. announced today that they have entered into a definitive agreement, under which the companies will be combined as maxIT Healthcare. The combined company is now better positioned to extend its presence throughout the healthcare IT professional services market, particularly in the area of Enterprise Resource Planning (ERP) system solutions.
Merck, known as MSD outside the United States and Canada, today announced the first presentation of results from an interim analysis of KEYNOTE-057, a Phase 2 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for previously treated patients with high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ or CIS plus papillary disease (Cohort A).
The grants, which are to be used to set up the framework for the health law's state insurance exchanges, will reportedly go to Kansas, Maryland, New York, Oklahoma, Oregon, Wisconsin and a consortium led by Massachusetts.
Results from a pre-clinical study show that the gene designated Bcl-6 is an oncogene - that is, one with the potential to cause a normal cell to become cancerous - but that certain peptide inhibitors can in effect inactivate it, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).
› Verified 6 days ago
Yong Li, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1095 Midway Rd, Menasha, WI 54952 Phone: 920-720-2300 Fax: 920-720-3806 | |
John Beld, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1095 Midway Rd, Menasha, WI 54952 Phone: 920-720-2300 | |
Dr. Robert Perzacki, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1820 Appleton Rd, Menasha, WI 54952 Phone: 920-996-2200 Fax: 920-996-2214 | |
Dr. Nathaniel Thomas Albrecht, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1095 Midway Rd, Menasha, WI 54952 Phone: 920-720-2300 | |
Matthew A Bayer, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1095 Midway Rd, Menasha, WI 54952 Phone: 920-720-3700 | |
Paul C Burney, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1095 Midway Rd, Menasha, WI 54952 Phone: 920-720-2300 Fax: 920-720-3719 |